SCHEMBL16620680

SCHEMBL16620680

Nc1ccc(CN2CCC2)c(F)c1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
ACHE P22303 2/20 0.56
ALDH1A1 P00352 4/20 0.51
NR1H2 P55055 1/20 0.48
CXCR3 P49682 3/20 0.47
DRD2 P14416 1/20 0.46
MAOA P21397 1/20 0.46
ADRA2B P18089 1/20 0.44
HTT P42858 1/20 0.42
CYP2A13 Q16696 1/20 0.41
MAPT P10636 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13495620 0.96 SMN1; SMN2 (0.67) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL30309475 0.85 NR1H2 (0.51) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL15688210 0.85 NR1H2 (0.51) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL2961101 0.85 KDM4E (0.49) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL922214 0.85 CYP2A13 (0.61) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL15542251 0.85 NR1H2 (0.67) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL34464853 0.82 ACHE (0.49) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL22172323 0.82 NR1H2 (0.52) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL22172215 0.82 NR1H2 (0.49) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2
SCHEMBL2010740 0.82 ACHE (0.65) KDM4ESMN1; SMN2ACHEALDH1A1NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
US-20150045255-A1 Endometrial Phase or Endometrial Cancer Biomarkers WALFISH, PAUL (CA) 2015-02-12 US disclosed